Idiopathic pulmonary fi brosis (IPF) is a chronic, lethal interstitial lung disease of unknown cause. The disease is characterized by scattered fi brotic lesions in various stages of progression ( 1 ) . The sentinel morphological lesion is the fi broblastic focus, which is composed of fi broblasts in a type I collagen -rich matrix ( 2 ) . Evidence for the critical role of the fi broblast in the relentless progression of IPF is prima facie: this is the cell that proliferates and deposits type I collagen in the alveolar wall, distorting alveolar architecture and impairing gas exchange ( 2 -5 ) . Although recent studies support the theory that IPF fi broblasts harbor intrinsic alterations of key components of their cellular machinery, large gaps in knowledge remain regarding the mechanisms conferring IPF fi broblasts with the capacity to proliferate and persist in a setting where normal fi broblasts display the tightly regulated proliferation essential for physiological repair ( 6 -12 ) .
The molecular mechanisms regulating fi broblast proliferation on collagen matrices are coming into focus. Seminal studies in the 1980s and 1990s demonstrated that polymerized (fi brillar) collagen, the natural form of type I collagen found in tissues, acts as a negative regulator of fibroblast proliferation, whereas monomeric collagen supports fi broblast proliferation ( 13 -15 ) . On the basis of this work, fi broblast interaction with polymerized collagen is believed to provide an important physiological mechanism to limit fi broproliferation after tissue injury. Integrins mediate cellular interactions with the extracellular matrix and are at the apex of signaling pathways that modulate key components of the cellular proliferative machinery ( 16 -26 ) . Fibroblast interactions with type I collagen are mediated predominantly by the ␣ 2 ␤ 1 integrin ( 19 ) . In this study, we demonstrate that ␤ 1 integrinpolymerized collagen interaction in normal fi broblasts activates the negative growth regulator, tumor suppressor phosphatase and tensin
Phosphoinositide 3-kinase (PI3K) -Akt -S6K1 signaling in control fi broblasts
To provide a context for our studies of IPF, we examined key signaling events regulating control fi broblast proliferation on type I collagen. Our previous work strongly links fi broblast responses to ␣ 2 ␤ 1 integrin -collagen interaction with Figure 1 . IPF fi broblasts display enhanced proliferation on polymerized collagen matrices. (A) Proliferation assay of control ( n = 8) and IPF ( n = 6) fi broblasts on monomeric and polymerized collagen. *, P < 0.01 and 0.005 for the ratio of proliferation of IPF fi broblasts on polymerized versus monomeric collagen compared with control fi broblasts at days 3 and 6, respectively. (B) Quantifi cation of DNA synthesis by BrdU incorporation in control ( n = 4) and IPF ( n = 5) fi broblasts on monomeric and polymerized collagen at day 3. *, P < 0.0001 for the percentage of BrdUpositive IPF and control fi broblasts at the indicated time. (C) Ratio of proliferation of wound ( n = 3) and IPF ( n = 6) fi broblasts on polymerized versus monomeric collagen at days 3 and 6 (*, P < 0.02 and 0.001, respectively). (D) Normal fi broblasts were exposed to TGF-␤ for 3 -6 d or left untreated, and cell numbers were quantifi ed (*, P < 0.05). (E) Proliferation assay of control ( n = 4) and IPF ( n = 5) fi broblasts on monomeric and polymerized collagen in defi ned media. Shown is the percent increase in cell number in response to the indicated growth factor treatment compared with cultures continued in the absence of growth factors at day 3. *, P < 0.05 or 0.001 for the proliferative response of IPF compared with control fi broblasts at the time in defi ned media containing insulin alone or insulin plus platelet-derived growth factor, respectively. Error bars represent SEM. Data are representative of three independent experiments.
by ␣ 2 or ␤ 1 blocking antibodies ( Fig. 2 C ) . There was no signifi cant synergistic eff ect on cell spreading using antibodies to ␣ 1, ␣ 3, ␣ 5, and ␣ V in combination with ␤ 1 over using the ␤ 1 blocking antibody alone ( Fig. 2 C ) . These data demonstrate that ligation of ␣ 2 ␤ 1 by monomeric collagen is primarily responsible for the activation of Akt when fi broblasts attach to collagen.
we used integrin blocking antibodies. Preincubation of control fi broblasts with ␣ 2 or ␤ 1 blocking antibodies attenuated the increase in Akt phosphorylation in response to attachment to monomeric collagen ( Fig. 2 B ) . Reagents blocking the ␣ 1, ␣ 3, ␣ 5, and ␣ V integrin subunits were much less effective in inhibiting Akt activation. Consistent with this, cell spreading on monomeric collagen was signifi cantly impaired (C) Fibroblasts were plated on tissue culture plates coated with monomeric collagen and blocked by BSA. Cells were allowed to spread for 30 min. Cell areas of a random 150 cells were quantifi ed by tracing the cell border using ImageJ software (available at http://rsb.info.nih.gov/ij/). (D) Western blot analysis of phospho-Akt and S6K1 in response to control fi broblast attachment to polymerized collagen in the absence of serum. (E) Western blot analysis of phospho-Akt and S6K1 in control fi broblasts cultured on monomeric or polymerized collagen in growth factor -replete media. One representative example is shown. (F) GD25, GD25 ␤ 1, and GD25 ␣ 2 ␤ 1 fi broblasts were cultured on monomeric (left) or polymerized (right) collagen in the presence of serum, and cell numbers were quantifi ed. (G) Proliferation assay of control fi broblasts expressing dominant-negative Akt (Ad-DN-Akt; left) or constitutively active p110 subunit of PI3K (AdPI3Kp110; right) and cultured on monomeric or polymerized collagen in growth factor -replete media, respectively. (top left) Western blot analyses of phosphoand total Akt. (bottom left) Shown is the percent change in cell growth. *, P < 0.01 and 0.001 for the percent change in fi broblast growth on monomeric collagen that was signifi cantly less in control fi broblasts expressing dominant-negative Akt compared with cells expressing control vector at days 3 and 6, respectively. (top right) Western blot analyses of phospho-and total Akt. (bottom right) Shown is the percent change in cell growth. *, P < 0.01 and 0.0001 for the percent change in fi broblast growth on polymerized collagen that was signifi cantly greater in control cells expressing constitutively active p110 subunit of PI3K compared with control vector at days 3 and 6, respectively. Error bars represent SEM. Data are representative of three independent experiments. the eff ect of enforced activation of PI3K on fi broblast proliferation on polymerized collagen. Enforced activation of PI3K by overexpression of the constitutively active p110 subunit of PI3K increased the level of phosphorylated Akt and enabled fi broblasts to overcome the antiproliferative eff ect of polymerized collagen ( Fig. 2 G , right) . These data demonstrate that the activity state of PI3K -Akt is a major component of the mechanism by which polymerized collagen negatively regulates fi broblast proliferation.
The PI3K -Akt -S6K1 pathway is pathologically regulated in IPF fi broblasts To characterize the PI3K -Akt -S6K1 signaling pathway in IPF fi broblasts, we examined Akt and S6K1 after attachment of IPF fi broblasts to monomeric collagen. Surprisingly, there was a muted increase in Akt and S6K1 phosphorylation compared with control fi broblasts ( Fig. 3 A ) . We have previously shown that ligation of ␤ 1 integrin by the ␤ 1 integrin activating antibody TS2/16 increases Akt phosphorylation in normal fi broblasts ( Fig. 3 B , left) ( 22 ) and, therefore, tested its eff ect on Akt in IPF fi broblasts. Ligation of ␤ 1 integrin by TS2/16 in IPF fi broblasts failed to increase Akt phosphorylation ( Fig. 3 B , right) . These data indicate that IPF fi broblast adhesion to monomeric collagen via ␣ 2 ␤ 1 results in attenuated activation of the Akt -S6K1 signal, a response opposite of control fi broblasts.
The attenuation of Akt phosphorylation in IPF fi broblasts in response to ligation of ␣ 2 ␤ 1 by collagen or ␤ 1 integrin activating antibody could result from a reduced level of integrin expression. However, we did not detect significant alterations in ␤ 1 integrin subunit expression in control compared with IPF fi broblasts (unpublished data). Changes in the cytoplasmic domain of integrins can aff ect the conformation of the extracellular domain. This mechanism is operational in normal cells and is termed inside-out signaling. To investigate the ligand binding/activation state of IPF fibroblasts, we used the 9EG7 monoclonal antibody, which recognizes ligand-induced epitopes on the human ␤ 1 integrin ( 31, 32 ) . FACS analysis of control and IPF fi broblasts revealed that both fi broblast lines bound comparable levels of 9EG7 antibody, indicating a similar ␤ 1 integrin activation state ( Fig. 3 C ) . Furthermore, full stimulation of ␤ 1 integrin in control and IPF fi broblasts was obtained with the activating TS2/16 antibody. Therefore, the reduced level of Akt and S6K1 activation in response to ligation of ␣ 2 ␤ 1 by monomeric collagen could not be explained by altered ␤ 1 integrin expression or activation state. To confi rm this, we examined focal adhesion kinase (FAK) phosphorylation. FAK is upstream of PI3K -Akt and can be used as a surrogate marker of integrin activation ( 21 ) . When serum-starved control and IPF fi broblasts were plated on monomeric collagen, the level of FAK tyrosine 397 phosphorylation was similar ( Fig. 3 D ) .
Current models for Akt regulation indicate that Akt phosphorylation is dependent on the activity of the upstream enzyme PI3K ( 23 ) . We examined PI3K activity in control When we examined the eff ect of fi broblast attachment to polymerized collagen on the state of the PI3K -Akt -S6K1 pathway, the pattern of signaling diff ered from that observed on monomeric collagen. The level of phosphorylated Akt increased modestly when fi broblasts attached to polymerized collagen ( Fig. 2 D ) , but S6K1 did not become phosphorylated. These fi ndings indicate that compared with monomeric collagen, the amplitude of the PI3K -Akt -S6K1 signaling pathway on polymerized collagen is attenuated.
After attachment to the matrix in the presence of growth factors, cells enter the cell cycle and proliferate. To examine the relationship between matrix state (polymerized vs. monomeric collagen) and the PI3K -Akt -S6K1 pathway during log-phase growth, control fi broblasts were cultured on monomeric or polymerized collagen in the presence of serum for 3 d. Akt and S6K1 phosphorylation were maintained during fi broblast proliferation on monomeric collagen. In contrast, the levels of phosphorylated Akt and S6K1 were suppressed on polymerized collagen ( Fig. 2 E ) . In the aggregate, these data show a tight relationship between matrix chemistry and activity of the PI3K -Akt -S6K1 pathway in control fi broblasts.
We have found that fi broblasts use ␣ 2 ␤ 1 to attach to collagen during the adhesion assay (serum-free conditions), and that this is associated with modulation of the PI3K -Akt -S6K1 signal. However, during the proliferation assay the cells are cultured in serum and may interact with other extracellular matrix molecules, such as fi bronectin, in addition to collagen. To examine which integrin receptors regulate fi broblast proliferation on collagen matrices, we performed our proliferation assay using GD25 ␣ 2 ␤ 1 integrin -null fi broblasts (GD25 cells) and GD25 cells reconstituted with ␤ 1 (GD25 ␤ 1A) or ␣ 2 ␤ 1 integrin (GD25 ␣ 2 ␤ 1A). GD25-null cells do not express ␤ 1 integrins, but they do express ␣ v ␤ 3, which they use to attach to collagen. GD25 ␤ 1 cells express some ␤ 1 integrins, but not ␣ 2 ␤ 1. GD25 ␣ 2 ␤ 1 cells express ␣ 2 ␤ 1 ( 28 -30 ). We found that GD25-null cells proliferate poorly on monomeric collagen. Interestingly, GD25 ␤ 1 cells were capable of proliferating on monomeric collagen as well as GD25 cells reconstituted with ␣ 2 ␤ 1 ( Fig. 2 F , left) . In contrast, we found that only GD25 ␣ 2 ␤ 1 cells proliferated on polymerized collagen ( Fig. 2 F , right) . Both GD25-null and GD25 ␤ 1 cells proliferated poorly on polymerized collagen. Our data suggest a scenario where, in addition to ␣ 2 ␤ 1, other ␤ 1 integrins may contribute to proliferation signaling on monomeric collagen, whereas ␣ 2 ␤ 1 predominately regulates proliferation on polymerized collagen.
To examine whether matrix confi guration, the PI3K -Akt -S6K1 pathway, and fi broblast proliferation were causally linked, we examined whether inhibiting PI3K using a dominant-negative Akt construct would attenuate fi broblast proliferation on monomeric collagen. Kinase-dead dominantnegative Akt decreased phosphorylated Akt and suppressed fi broblast proliferation on monomeric collagen (48% inhibition of proliferation at day 6 compared with fi broblasts treated with empty vector; Fig. 2 G , left) . We also analyzed and IPF fi broblasts by examining the amounts of phosphatidylinositol 3-phosphate produced in response to ligation of ␤ 1 integrin by the TS2/16 activating antibody. PI3K activity (I) Proliferation assay of IPF fi broblasts expressing dominant-negative Akt (left) or treated with 100 nM rapamycin (right) and cultured on polymerized collagen in growth factor -replete media. Shown is the percent change in cell growth. *, P < 0.01 and 0.0001 for the percent change in cell growth on polymerized collagen that was signifi cantly less in IPF fi broblasts expressing dominant-negative Akt at days 3 and 6, respectively; or P < 0.002 or 0.001 for the percent change in cell growth on polymerized collagen that was signifi cantly less in IPF fi broblasts treated with rapamycin at days 3 or 6, respectively. Error bars represent SEM. Data are representative of three independent experiments from one IPF cell line. (J) IPF fi broblasts were preincubated with the indicated integrin blocking antibody and plated on polymerized collagen in growth factor -replete media in the presence of antibody. BrdU staining as a measure of DNA synthesis was assessed at 24 h. Error bars represent SEM. Data are representative of three independent experiments from three IPF cell lines.
was reduced in IPF fi broblasts treated with TS2/16 antibody compared with control ( Fig. 3 E ) . This suggests that the decreased level of Akt and S6K1 phosphorylation seen in fi broblasts on collagen, we examined PTEN protein expression when fi broblasts were cultured on monomeric and polymerized collagen in the presence of serum. As a function of time, control fi broblast PTEN expression decreased on monomeric collagen and increased on polymerized collagen ( Fig. 4 A ) , whereas in IPF fi broblasts PTEN expression was invariant ( Fig. 4 B ) . However, total PTEN protein levels in IPF fi broblasts on polymerized collagen were modestly lower compared with monomeric collagen. Because the abundance of PTEN protein in IPF fi broblasts was only modestly decreased, it remained unclear whether fi broblast interaction with polymerized collagen was associated with a decrease in PTEN activity.
To assess PTEN activity, IPF and control fi broblasts were cultured on collagen, PTEN was immunoprecipitated, and activity was quantifi ed. Fibroblasts in uninjured tissue have a low proliferation rate. To provide a reference value for PTEN activity under proliferation-prohibitive conditions, PTEN activity was measured in quiescent cultures of serum-starved fi broblasts. We then compared fi broblast PTEN activity on monomeric and polymerized collagen in the presence of serum growth factors with PTEN activity under proliferationprohibitive conditions. In control fi broblasts, PTEN activity under proliferation-prohibitive condition was high. When these fi broblasts were cultured on monomeric collagen in the presence of serum -a condition associated with active proliferation -there was a signifi cant decrease in PTEN activity ( Fig. 4 C , left) , whereas on polymerized collagen -which represses proliferation -PTEN activity gradually increased over 3 d to the level seen under proliferation-prohibitive conditions. When IPF fi broblasts were cultured under proliferation-prohibitive conditions, PTEN activity was high, similar to control cells ( Fig. 4 D , left) . However, when we examined PTEN activity on polymerized to monomeric collagen, the response was opposite to that of control fi broblasts. There was a sharp decrease in PTEN activity on polymerized compared with monomeric collagen ( Fig. 4 D , left) . To confi rm these results, we examined PI3K activity in control and IPF fi broblasts by examining the amounts of phosphatidylinositol 3-phosphate produced in response to culture on collagen. When control fi broblasts were cultured on polymerized collagen, the level of PI3K activity decreased 19% compared with monomeric collagen ( Fig. 4 C , right ). In contrast, the level of PI3K activity increased 45% when IPF fi broblasts were cultured on polymerized collagen ( Fig. 4 D , right) . These data indicate that in response to polymerized collagen, IPF fi broblasts display inappropriately low PTEN function and concomitant activation of Akt and proliferation.
Recent work suggests that cytosolic PTEN needs to be recruited to the plasma membrane, where it is activated and is then in the right location to inhibit PI3K -Akt ( 35, 36 ) . Thus, total PTEN levels may not correlate well with activity. To address this issue, we analyzed the levels of membrane-associated PTEN from control and IPF fi broblasts cultured on polymerized collagen. IPF fi broblast membrane -associated PTEN was markedly decreased compared with controls ( Fig. 4 E ) .
response to ligation of ␤ 1 integrin by monomeric collagen or activating antibody in IPF fi broblasts is caused by a reduced level of PI3K activity.
Having seen aberrant activity of the PI3K -Akt -S6K1 signaling pathway in IPF fi broblasts attaching to monomeric collagen, we examined the pathway after attachment to polymerized collagen. In contrast to control fi broblasts, we found that both Akt and S6K1 became phosphorylated when IPF fi broblasts attached to polymerized collagen ( Fig.  3 F ) . The increase in Akt phosphorylation was largely inhibited by blocking antibodies to the ␣ 2 and ␤ 1 integrin subunits, indicating that activation of Akt in response to IPF fi broblast adhesion to polymerized collagen is mediated through ␣ 2 ␤ 1 ( Fig. 3 G ) .
We next examined the eff ect of matrix state on the PI3K -Akt -S6K1 pathway on actively proliferating IPF fibroblasts. In contrast to the pattern observed in control fi broblasts, we found that the levels of phosphorylated Akt and S6K1 were elevated when IPF fi broblasts were cultured on polymerized collagen ( Fig. 3 H ) , indicating that the PI3K pathway was aberrantly activated. These data are consistent with the idea that IPF fi broblasts elude the antiproliferative eff ects of polymerized collagen by aberrantly activating the PI3K -Akt -S6K1 signaling pathway.
To test this directly, we inhibited the PI3K -Akt pathway by infecting IPF fi broblasts with an adenoviral vector containing a dominant-negative Akt construct and examined proliferation on polymerized collagen. Kinase-dead Akt decreased fi broblast proliferation on polymerized collagen by ‫ف‬ 50% compared with empty vector ( Fig. 3 I , left) . Consistent with this, inhibition of the downstream Akt effectors mammalian target of rapamycin and S6K1 by rapamycin reversed the aberrant proliferation of IPF fi broblasts on polymerized collagen ( Fig. 3 I , right) . The ability of IPF fi broblasts to circumvent the negative regulatory eff ects of polymerized collagen is caused by aberrant activation of the PI3K -Akt -S6K1 pathway.
Similar to control fi broblasts, IPF fi broblasts use ␣ 2 ␤ 1 to attach to polymerized collagen. To address which integrins IPF fi broblasts use for proliferation signaling on polymerized collagen, we cultured IPF fi broblasts pretreated with integrin blocking antibodies on polymerized collagen in the presence of serum. At 24 h, we analyzed BrdU staining as a measure of DNA synthesis. ␣ 2 and ␤ 1 blocking antibodies attenuated BrdU staining compared with IgG control ( Fig. 3 J ) . Other blocking antibodies had minimal eff ect on DNA synthesis. Thus, IPF fi broblasts predominantly use ␣ 2 ␤ 1 for proliferation signaling on polymerized collagen.
Regulation of the tumor suppressor PTEN is altered in IPF fi broblasts PTEN phosphatase negatively regulates integrin growth signaling by inhibiting Akt ( 33, 34 ) . PTEN activity is determined by its abundance and phosphorylation state ( 35 -38 ) . 
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S6K1 and maintenance of high PTEN activity, we examined whether down-regulation of PTEN would enable control fibroblasts to overcome the antiproliferative eff ects of polymerized collagen. Control fi broblasts were transfected with PTEN or control siRNA and plated on polymerized collagen. PTEN siRNA knocked down PTEN expression ( Fig. 5,  A and B ) and augmented their ability to proliferate on polymerized collagen compared with control ( Fig. 5 C ) .
This suggests that an inadequate recruitment of cytosolic PTEN to the membrane may account for inappropriately low PTEN activity in IPF fi broblasts on polymerized collagen.
Ectopic expression of PTEN in IPF fi broblasts reverses the abnormal proliferative phenotype
Because inhibition of control fi broblast proliferation on polymerized collagen is associated with suppression of PI3K -Akt - (C and D) PTEN phosphatase assay showing the percent change in PTEN activity in control ( n = 3; C, left) or IFP ( n = 3; D, left) fi broblasts cultured on polymerized or monomeric collagen in growth factor -replete media compared with cells cultured under proliferation-prohibitive conditions. *, P < 0.001 for PTEN activity in control fi broblasts on polymerized collagen that was signifi cantly higher at day 3 compared with monomeric collagen; P < 0.01 for PTEN activity in IPF fi broblasts on polymerized collagen that was signifi cantly less on day 3 compared with monomeric collagen. Shown is PI3K activity in control (C, right) and IPF (D, right) fi broblasts cultured on monomeric or polymerized collagen in growth factor -replete media for 3 d. *, P < 0.005 for PI3K activity in control fi broblasts cultured on polymerized collagen that was signifi cantly less at day 3 compared with monomeric collagen; or P < 0.05 for PI3K activity in IPF fi broblasts cultured on polymerized collagen that was signifi cantly higher at day 3 compared with monomeric collagen. Error bars represent SEM. (E) PTEN protein levels in membrane and cytosolic fractions of cell lysates were measured by Western blot analysis. Data are representative of three independent experiments. blasts cultured on polymerized collagen ( Fig. 6 C ) . Thus, elevation of PTEN activity in IPF fi broblasts restores the normal pattern of proliferation on polymerized collagen, whereas pathologically low PTEN activity can account for the ability of IPF fi broblasts to circumvent the antiproliferative eff ects of polymerized collagen.
Can PTEN defi ciency lead to a more durable fi broproliferative response after tissue injury? To address this issue, we used PTEN haploinsuffi cient mice. Using a well-characterized cutaneous wound model, a 2 × 2 -cm skin wound was made on the middorsal surface of PTEN wild-type or haploinsuffi cient mice ( 39 ) . We measured the reduction in wound surface area by planimetry as a function of time. There was an ‫ف‬ 10-fold greater reduction in wound surface area of PTEN wild-type compared with haploinsufficient mice at day 28 after wounding ( Fig. 7 A ) , indicating that wound repair was delayed in PTEN-defi cient mice.
We performed histological analysis of the wounds as a function of time. We focused our analysis at days 18 and 28, as large diff erences in granulation tissue size were apparent at these times. Histological analysis of day 18 wounds revealed markedly increased cellularity of the granulation tissue of PTEN haploinsuffi cient ( Fig. 7 B , top left) compared with wild-type mice ( Fig. 7 B , top right) . We sought to determine why the granulation tissue of PTEN haploinsuffi cient mice displayed increased cellularity. We reasoned that it could be caused by enhanced proliferation, reduced apoptosis, or both. We used Ki67 staining as a marker of proliferation. Abundant Ki67 staining was present both in day 18 wound granulation tissue and in the newly formed epithelium overlying the wound ulcer in PTEN haploinsuffi cient mice ( Fig. 7 B , middle left). There was little Ki67 staining in the granulation tissue of PTEN wild-type mice, whereas the overlying regenerating epithelium stained positive ( Fig. 7 B , middle right) . Immunohistochemical analysis of PTEN haploinsuffi cient granulation tissue revealed the presence of abundant ␣ -smooth muscle actin -expressing mesenchymal cells ( Fig. 7 B , bottom right) .
To determine whether decreased PTEN activity accounted for the enhanced proliferation of IPF fi broblasts on polymerized collagen, we infected IPF fi broblasts with an adenoviral vector containing wild-type PTEN. This elevated PTEN expression and suppressed phospho-Akt ( Fig. 6 A ) . Ectopic PTEN also inhibited two downstream targets of the PI3K -Akt pathway, S6K1 and translation initiation factor eIF4F ( Fig. 6, A and B ) , and inhibited DNA synthesis in IPF fi bro- 
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We also analyzed apoptosis in the granulation tissue of PTEN wild-type and haploinsuffi cient mice by examining cleaved caspase 3 expression. No diff erences in cleaved caspase 3 staining were apparent (unpublished data). For controls, no immunoreactivity was seen when IgG isotype control antibodies were substituted for the primary antibody (unpublished data). These data suggest that a more durable fi broproliferative response accounts for the abundance of ␣ -smooth muscle actin -expressing myofi broblasts and the delayed resorption of granulation tissue in PTEN-defi cient mice after tissue injury.
PTEN-defi cient mice have increased fi brosis after bleomycin-induced lung injury
To examine the eff ect of PTEN defi ciency on the development of pulmonary fi brosis, PTEN haploinsuffi cient or wildtype mice were given bleomycin intratracheally, and collagen content was analyzed by Sircol assay 21 d later. The collagen content of PTEN-defi cient mice was increased 55% compared with wild-type mice (11.12 ± 3.42 μ g/g vs. 17.25 ± 2.47 μ g/g body weight; P < 0.005; Fig. 8 A ) . Collagen deposition in the mice was evaluated by Trichrome staining. Consistent with the Sircol assay, PTEN-defi cient mice displayed augmented collagen deposition after bleomycin compared with wild-type mice ( Fig. 8 B , middle and bottom) . Collectively, our in vivo studies indicate that PTEN deficiency is associated with a more durable fi broproliferative response leading to exaggerated fi brosis.
Akt is activated in the fi broblastic foci of human IPF tissue Our in vitro experiments indicate that the Akt -S6K1 pathway is aberrantly activated in IPF fi broblasts cultured on polymerized collagen. To analyze the activation state of Akt in IPF lung tissue in vivo, we performed immunohistochemistry on lung tissue from fi ve IPF patients examining phospho-Akt expression. Consistent with our in vitro studies, phospho-Aktpositive cells were present in the fi broblastic foci of IPF tissue (image is representative of fi brotic foci from the four other patient samples; Fig. 9 C ) . In contrast, although the epithelium and endothelium of normal lung tissue stained positive for phospho-Akt, no phospho-Akt could be detected in the mesenchymal or smooth muscle cells of normal lung parenchyma ( Fig. 9 A ) . As a control, when fi brotic lung tissue was stained with an irrelevant primary antibody (anti-p53) plus secondary antibody, scant immunoreactivity was present ( Fig. 9 E ) . No immunoreactivity was seen when IPF and normal lung tissue were stained with secondary antibody without primary antibody (unpublished data). When we used an antibody that recognizes total PTEN, we found that PTEN expression was prominent in the epithelium, endothelium, and mesenchymal cells in normal lung tissue ( Fig. 9 B ) . PTEN expression could also be seen in cells in the fi broblastic foci of IPF tissue ( Fig. 9 D ) . This is consistent with our in vitro fi ndings, which demonstrate the presence of PTEN protein expression in IPF fi broblasts cultured on collagen. It is important to note the limitations of the PTEN immunohistochemical studies. PTEN activity is dependent on both its expression and phosphorylation state. Double staining for Ki67 and ␣ -smooth muscle actin suggested the presence of proliferating myofi broblasts in the PTEN haploinsuffi cient granulation tissue ( Fig. 7 B , bottom  left) . By day 28, the wounds of PTEN-defi cient mice were incompletely healed, whereas the wounds of the PTEN wildtype mice were nearly completely healed. At this time, there was still a mild persistent proliferative response in PTENdefi cient compared with wild-type mice (unpublished data). expansion of the fi broblast focus by proliferating myofi broblasts depositing type I collagen leads to permanently scarred alveoli. Although recent studies indicate that IPF fi broblasts display a distinct pathological phenotype ( 6 -12 ) , the mechanisms diff erentiating IPF fi broblasts from their normal counterparts remain poorly understood. In this study, we present results providing direct evidence for defective negative regulation of the proliferative pathway in IPF fi broblasts that support the theory that the pathogenesis of IPF involves abnormalities in the fi broblast cellular machinery.
When cells attach to the extracellular matrix, a matrix recognition signal is generated by integrin -ligand binding. This is termed " outside-in signaling " and activates specifi c signal transduction pathways that regulate cell function. In the case of normal fi broblasts, ligation of ␤ 1 integrin by monomeric collagen generates a matrix recognition signal characterized by an increase in Akt and S6K1 activity in a PI3K-dependent manner. Facilitating this increase in Akt and S6K1 activity is a relaxation in the suppressive activity of PTEN. PTEN is a tumor suppressor phosphatase and a major inhibitor of the PI3K -Akt pathway whose baseline activity is believed to be constitutively high ( 21 ) . In this study, we demonstrate that a relaxation of PTEN ' s suppressive activity supports normal fi broblast proliferation on monomeric collagen. In contrast, seminal studies have demonstrated that polymerized collagen functions as a negative regulator of fi broblast proliferation by promoting arrest in the G1 phase of the cell cycle ( 15 ) . We show that normal fi broblast interaction with polymerized collagen via ␤ 1 integrin, which is the physiological form of collagen that fi broblasts interact with, results in high PTEN activity, causing suppression of the PI3K -Akt -S6K1 pathway and proliferation. Thus, the contact of fi broblasts with polymerized collagen provides a physiological mechanism to limit excess fi broproliferation.
It is important to note that for our in vitro studies, the critical comparison was between proliferation signaling in control and IPF fi broblasts on polymerized collagen. In contrast to control fi broblasts where high PTEN activity inhibits PI3K -Akt, we have discovered that in IPF fi broblasts, ␤ 1 integrin interaction with polymerized collagen generates an aberrant matrix recognition signal characterized by activated Akt -S6K1 activity because of inappropriately low PTEN activity. Importantly, using PTEN haploinsuffi cient mice and two in vivo models of tissue injury, a well characterized cutaneous wound healing model and bleomycin-induced lung injury, we confi rm that a defi ciency in PTEN activity results in a more durable fi broproliferative response after tissue injury and leads to pathological fi brosis.
PTEN activity is a function of abundance and phosphorylation state ( 35 -38, 40 ) . Current models for PTEN activation suggest that cytosolic PTEN is recruited to the plasma membrane, where it is activated by dephosphorylation. Membraneassociated PTEN is then in the right location to inhibit PI3K ( 35, 36 ) . Our data indicate that PTEN activity is inappropriately low in IPF fi broblasts in response to integrin-polymerized collagen interaction. We have found that membrane-associated PTEN is decreased in IPF fi broblasts compared with controls.
Analyzing total PTEN expression may not accurately refl ect PTEN activity. Thus, it remains unclear whether PTEN activity is altered in vivo in IPF. Nevertheless, consistent with our in vitro fi ndings that the Akt pathway is aberrantly activated in IPF fi broblasts, these data verify that Akt is activated in vivo in IPF fi broblastic foci.
DISCUSSION
The pathogenesis of IPF remains incompletely understood. However, prima facie evidence for a key role for the fi broblast in IPF is established by the observation that progressive pared with normal fi broblasts when they are cultured on polymerized collagen matrices, and that this is associated with reduced membrane-associated PTEN. Thus, our data do not link IPF with a defi ciency of PTEN protein expression. Rather, our studies provide direct mechanistic evidence that the pathological ability of IPF fi broblasts to elude the antiproliferative properties of polymerized collagen is caused by defective regulation of PTEN function in response to their interaction with collagen via integrin.
A central unresolved issue in IPF has revolved around the question of whether IPF fi broblasts are normal fi broblasts that behave abnormally because they reside in a microenvironment consisting of profi brotic cytokines or whether they have acquired a distinct pathological phenotype that is stable and does not depend on continued exposure to profi brotic molecules. Our study suggests that IPF fi broblasts are not normal or wound fi broblasts whose pathological behavior depends on continuous exposure to profi brotic cytokines. Rather, IPF fi broblasts have acquired a distinct stable pathological phenotype that persists despite an absence of profi brotic cytokines. While our study was in progress, a study was published that may provide insight into how these cells have acquired this abnormal phenotype. This study demonstrated that when epithelial cells are chronically exposed to TGF-␤ (30 d), they undergo epithelialmesenchymal transition (EMT) ( 42 ) . These cells display Akt phosphorylation that persists despite withdrawal of TGF-␤ . In addition, two recent studies suggest an EMT origin for IPF fibroblasts ( 43, 44 ) . The implication of our work in the context of these studies suggests that IPF fi broblasts may represent cells that have undergone EMT and have acquired a stable pathological phenotype as part of the transdiff erentiation process. In conclusion, our data demonstrate that the IPF fi broblast phenotype is characterized by persistent activation of the PI3K -Akt pathway caused by inappropriately low PTEN activity that confers a pathological proliferative response with the capacity to elude the antiproliferative properties of fi brillar collagen.
MATERIALS AND METHODS
Cell culture
Seven primary fi broblast lines were established from IPF patients. Cells were obtained from lungs removed at the time of transplantation or death. The diagnosis of IPF was supported by history, physical examination, pulmonary function tests, and typical high resolution chest computed tomography fi ndings of IPF. In all cases, the diagnosis of IPF was confi rmed by microscopic analysis of lung tissue and demonstrated the characteristic morphological fi ndings of usual interstitial pneumonia. All patients fulfi lled the criteria for the diagnosis of IPF as established by the American Thoracic Society and the European Respiratory Society ( 45 ) . Seven normal primary control adult human lung fi broblast lines were used. One was purchased from American Type Culture Collection (human lung fi broblast 210), and six were established from histologically normal lung tissue adjacent to carcinoid tumor ( n = 5) or adjacent to radiation-induced fi brotic lung tissue ( n = 1). One diseased control primary human fi broblast line was derived from a patient with chronic obstructive pulmonary disease at the time of lung transplantation. Primary lung fi broblast lines were generated by explant culture and cultured in high glucose DMEM containing 10% FCS. Fibroblasts were used between passages fi ve and eight. Cells were characterized as fi broblasts as previously described ( 46 ) . Use of human tissues was approved by the Institutional Review Board at the University of Minnesota.
Our data suggest a scenario where in response to IPF fi broblast interaction with polymerized collagen via integrin, there is defi cient recruitment of cytosolic PTEN to the membrane. This would result in a failure of PTEN to be activated. Inappropriately low PTEN activity would then facilitate aberrant activation of the PI3K -Akt signal and enable IPF fi broblasts to elude the proliferative-suppressive eff ects of polymerized collagen.
A previous study presented evidence that PTEN expression is low in IPF tissue compared with normal lung tissue suggesting that a defi ciency in PTEN expression is associated with pulmonary fi brosis ( 41 ) . Our study off ers a diff erent explanation for the role of PTEN in IPF. Unlike the fi ndings in this previous study, we have not found that PTEN protein expression is decreased in IPF fi broblasts compared with normal fi broblasts during routine tissue culture. We have found that PTEN activity is inappropriately low in IPF fi broblasts com- 
Bleomycin model of lung injury
Mice were anesthetized with sodium pentobarbital. 0.05 U bleomycin dissolved in sterile saline was instilled into the trachea. Lungs were harvested on day 21 after bleomycin. Total lung collagen levels were determined in both lungs by Sircol assay according to the manufacturer ' s instructions (Accurate).
Immunohistochemistry
Immunohistochemical studies were performed on frozen sections prepared from lung specimens obtained from patients undergoing lung transplantation for IPF ( n = 5), and from surgical specimens showing normal lung parenchyma distant from tumor nodule ( n = 5). The avidin -biotin complex immunoperoxidase technique was used. Primary antibodies included phospho-Akt (ser473; Cell Signaling Technology) and total PTEN (6H2.1; Cascade Bioscience).
Data analysis
Comparisons of data among each experiment were performed with the unipolar unpaired or paired Student ' s t test. All experiments were replicated a minimum of three times. Data are expressed as mean ± SD. P < 0.05 were considered signifi cant.
